Balakrishna compassion for cancer patients, smile on Swapna face

Balakrishna compassion for cancer patients
Balakrishna compassion for cancer patients

Once again Nandamuri Balakrishna has produced that he has golden heart. This time Balakrishna has helped a cancer patient named Swapna, who is getting the treatment in Basavataram Cancer hospital. Swapna’ father is a lorry driver and his financial condition is not good. After hearing the health condition of Swapna, managing trustee and chairman of Basavataram Cancer hospital, Nandamuri Balakrishna promised her family that he would take care of  her treatment. Balakrishna became a reason for a smile on Swapna’ face.

Balakrishna who promised the cancer patient Swapna, is taking care of her expensive treatment. Swapna, a resident of Anantapuram, who is studying in intermediate, is suffering from bone cancer. And Balakrishna has been looking after Swapna’ condition from the past couple of years.

Now few pics of Balakrishna meeting Swapna and interacting with her, are going viral on the social media and Legend star’ fans are feeling proud today. Sources also confirmed the news that Balakrishna took up the responsibility of Swapna’ treatment.

 Nandamuri Balakrishna is doing great social service through Basavaramatarakam cancer hospital.

On the work side, Nandamuri Balakrishna is currently working for his upcoming action entertainer Ruler, which is progressing at the brisk pace in the direction of KS Ravikumar.   The movie which has  Sonal Chauhan and Vedhika in the female leads,   is being produced by C Kalyan under the banner of CK Entertainment. Bhumika Chawla is playing the important role. The makers are planning to release the film on 20th December. It is heard that Balakrishna will make his screen presence in dual avatar.

Nandamuri Balakrishna was last seen in NTR biopic , the movie which was based on his late father, and  Chief Minister of united Andhra Pradesh Nandamuri Taraka Rama  Rao. It was released in two parts as – NTR Kathanayakudu and NTR Mahanayakudu, but ended up commercially flop at the box office.